False Price Reports
|
Pharmaceutical companies, pharmacies, hospitals, and other healthcare providers must report certain cost and price information to Medicare and Medicaid. This cost and price information is used by the government to establish reimbursement rates under Medicare, Medicaid, and other government healthcare programs.
Submitting false cost or price information can result in civil and criminal liability under the federal False Claims Act and other statutes. If you are under investigation or have been charged with a crime -- or if you are aware of false costs or pricing reports submitted to Medicare or Medicaid -- then you should consult with an experienced healthcare fraud lawyer immediately to protect your rights. To arrange a free and confidential consultation, call John Howley at (212) 601-2728 to schedule a free a confidential consultation. Examples of False Price Reports
Medicare Part D Fraud - Prescription Drug Prices
Two elderly Medicare recipients will share almost one million dollars as a reward for bringing a False Claims Act case against RxAmerica, a subsidiary of retail pharmacy chain CVS Caremark Corporation. The reward is part of a $5.25 million settlement the company will pay to resolve allegations that gave the government false prices for its Medicare’s Prescription Drug Program, known as Medicare Part D. Click here to read more.... False Average Sales Price (ASP) Reports Former pharmaceutical sales representative Mark Giddarie will receive an $18.5 million reward for helping the government pursue a False Claims Act lawsuit against Sanofi US. The reward will be paid out of Sanofi's $109 million settlement to resolve allegations that it gave doctors kickbacks in the form of free products and submitted false average sales price (ASP) reports to the government. Click here to read more.... False Pharmaceutical Price Reports Pfizer Inc. and Endo Pharmaceuticals agreed to resolve Medicaid fraud allegations by paying the State of Texas a total of $36.34 million. The government alleged that Pfizer and Endo filed the false price reports in order to increase the "spread" between the Medicaid reimbursement amount and the actual market price, thereby inducing pharmacies and other providers to purchase their products. Click here to read more.... False Pharmaceutical Price Reports Amgen Inc. has agreed to pay $612 million to settle allegations that it engaged in false price reporting practices, including knowingly submitting false Average Sales Prices, Best Prices, and Average Manufacturer Prices for several drugs.. Click here to read more.... |
John Howley, Esq.
The Howley Law Firm P.C. 350 Fifth Avenue, 59th Floor New York, New York 10118 (212) 601-2728 
[object Object]
|
